CLNN Clene Inc.
Healthcare$6.70-1.62%ClosedMarket Cap: $69.1M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
-4.15
P/S
515.38
EV/EBITDA
-3.55
DCF Value
$-1.80
FCF Yield
-26.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
-182.1%
Operating Margin
-15535.1%
Net Margin
-25009.7%
ROE
233.9%
ROA
-154.7%
ROIC
-118.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $15.0K | -2266.7% | $-2.1M | $-8.1M | $— | — |
| Q4 null | $77.0K | 70.1% | $-7.2M | $-9.2M | $— | — |
| FY null | $200.0K | 78.5% | $-23.1M | $-26.2M | $— | — |
| Q3 null | $15.0K | 100.0% | $-5.6M | $-8.8M | $— | — |
| Q2 null | $27.0K | 100.0% | $-5.9M | $-7.4M | $— | — |
| Q1 null | $81.0K | 75.3% | $-4.1M | $-751.0K | $— | — |
| Q4 null | $91.0K | 80.2% | $-8.7M | $-13.5M | $— | — |
| FY null | $342.0K | 79.5% | $-33.1M | $-39.4M | $— | — |
| Q3 null | $87.0K | 79.3% | $-7.8M | $-8.0M | $— | — |
| Q2 null | $91.0K | 80.2% | $-7.4M | $-6.8M | $— | — |
| Q1 null | $73.0K | 78.1% | $-9.2M | $-11.1M | $— | — |
| Q4 2023 | $170.0K | -170.6% | $-9.9M | $-10.2M | $-1.58 | — |